Abstract：Prostate cancer is increasing year by year in our country. Diagnosis of early prostate cancer is important. With the development of medical imaging technology, multimodality image-guided biopsy has improved the detection rate of prostate cancer, and reduced the complications. This review focused on the present status of and advances in multimodality imaging technology-guided biopsy for prostate cancer.
[1] 韩苏军,张思维,陈万青,等.中国前列腺癌发病现状和流行趋势分析.临床肿瘤杂志,2013,18(4):330-334. [2] Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin, 2016,66(2):115-132. [3] 付遵峰,段秀芳,杨秀华,等. 经直肠超声引导下前列腺癌穿刺活检的现状与进展.中华男科学杂志,2015,21(3):272-276. [4] Dominguez-Escrig JL, McCracken SR, Greene D. Beyond diagnosis: evolving prostate biopsy in the era of focal therapy. Prostate Cancer, 2011:386207. [5] Birs A, Joyce PH, Pavlovic ZJ, et al. Diagnosis and monitoring of prostaticlesions: A Comparison of three modalities: Multiparametric MRI, fusion MRI/Transrectal ultrasound (TRUS), and traditional TRUS. Cureus, 2016,8(7):e702. [6] Tong ZH, Wang RF. Advancement of clinical application based on multi-molecualr imaging. Computerized Tomography Theory & Applications, 2014,23(4):707-714. [7] Cool DW, Zhang X, Romagnoli C, et al. Evaluation of MRI-TRUS fusion versus cognitive registration accuracy for MRI-targeted, TRUS-guided prostate biopsy. AJR Am J Roentgenol, 2015,204(1):83-91. [8] Cool D, Downey D, Lzawa J, et al. 3D prostate model formation from non-parallel 2D ultrasound biopsy images. Med Image Anal, 2006,10(6):875-887. [9] Long JA, Daanen V, Moreau-Gaudry A, et al. Prostate biopsies guided by three-dimensional real-time (4-D) transrectal ultrasonography on a phantom: comparative study versus two-dimensional transrectal ultrasound-guided biopsies. Eur Urol, 2007,52(4):1097-1104. [10] Pallwein L, Mitterberger M, Struve P, et al. Comparison of sonoelastography guided biopsy with systematic biopsy: impact on prostate cancer detection. Eur Radiol, 2007,17(9):2278-2285. [11] Brock M, Bodman CP, Calisaar RJ, et al. The impact of real-time elastography guiding a systematic prostate biopsy to improve cancer detection rate: a prospective study of 353 PCa patients. J Urol, 2012,187(6):2039-2043. [12] Sano F, Terao H, Kawahara T, et al. Contrast-enhanced ultrasonography of the prostate: various imaging findings that indicate prostate cancer. BJU Int, 2011,107(9):1404-1410. [13] Strazdin A, Krumina G, Sperga M. The value and limitations of contrast-enhanced ultrasound in detection of prostate cancer. Anticancer Res, 2011,31(4):1421-1426. [14] Mitterberger M, Pinggera GM, Hornigher W, et al. Comparison of contrast enhanced color Doppler targeted biopsy to conventional systematic biopsy: impact on Gleason score. J Urol, 2007,178(2):464-468. [15] 王燕,高旭,阳青松,等.3D打印技术辅助认知融合在前列腺穿刺活检术中的应用.临床泌尿外科杂志,2016,31(2):104-107. [16] Wang Y, Cheng JZ, Ni D, et al. Towards personalized statistical deformable model hybrid point matching for robust MR-TRUS registration. IEEE Trans Med Imaging, 2016,35(2):589-604. [17] Singh AK, Kruecker J, Xu S, et al. Initial clinical experience with real-time transrectal ultrasonography-magnetic resonance imaging fusion-guided prostate biopsy. BJU Int, 2008,101(7):841-845. [18] Ukimura O, Desai MM, Palmer S, et al. 3-Dimensional elastic registration system of prostate biopsy location by real-time 3-dimensional transrectal ultrasound guidance with magnetic resonance/transrectal ultrasound image fusion. J Urol, 2012,187(3):1080-1086. [19] Sonn GA, Chang E, Natarajan S, et al. Value of targetad prostate biopsy using magnetic resonance ultrasound fusion in men with prior negative biopsy and elevated prostate-specific abtigen. Eur Urol, 2014,65(4):809-815. [20] Jiang X, Zhang J, Tang J, et al. Magnetic resonance imaging - ultrasound fusion targeted biopsy outperforms standard approaches in detecting prostate cancer: A meta-analysis. Mol Clin Oncol, 2016,5(2):301-309. [21] Jagannathan NR. Prostate MR: Current status,challenges and future directions. NMR Biomed, 2014,27(1):1-2. [22] Barentsz JO, Richenberg J, Clements R, et al. ESUR prostate MR guidelines 2012. Eur Radiol, 2012,22(4):746-757. [23] Bratan F, Niaf E, Melodelima C, et al. Influence of imaging and histological factors on prostate cancer detection and localisation on multiparametric MRI: a prospective study. Eur Radiol, 2013,23(7):2019-2029. [24] Heidenreich A, Bastian PJ, Bellmunt J, et al. EAU guidelines on prostate cancer. Eur Urol, 2014,65(1):124-137. [25] D'Amico AV, Tempany CM, Cormack R, et al. Transperineal magnetic resonance image guided prostate biopsy. J Urol, 2000,164(2):385-387. [26] Zangos S, Melzer A, Eichler K, et al. MRcompatible assistance system for biopsy in a high-field-strength system: initial results in patients with suspicious prostate lesions. Radiology, 2011,259(3):903-910. [27] Zamecnik P, Schouten MG, Krafft AJ, et al. Automated real-time needle-guide tracking for fast 3-T MR-guided transrectal prostate biopsy: a feasibility study. Radiology, 2014,273(3):879-886. [28] Hoeks CM, Schouten MG, Bomers JG, et al. Three Tesla magnetic resonance-guided prostate biopsy in men with inceased prostate-specific antigen and repeated, negative, random, systematic, transrectal ultrasound biopsies: detection of clinically significant prostate cancers. Eur Urol, 2012,62(5):902-909. [29] Tilak G, Tuncali K, Song SE, et al. 3T MR-guided in-bore transperineal prostate biopsy: A comparison of robotic and manual needle-guidance templates. J Magn Reson Imaging, 2015,42(1):63-71. [30] Egbers N, Schwenke C, Maxeiner A, et al. MRI-guided core needle biopsy of the prostate: acceptance and side effects. Diagn Interv Radiol, 2015,21(3):215-221. [31] Dianat SS, Carter HB, Macura KJ. Magnetic resonance-guided prostate biopsy. Magn Reson Imaging Clin N Am, 2015,23(4):621-631. [32] Felker ER, Lee-Felker SA, Feller J, et al. In-bore magnetic resonance-guided transrectal biopsy for the detection of clinically significant prostate cancer. Abdom Radiol (NY), 2016,41(5):954-962. [33] Moore CM, Robertson NL, Arsanious N, et al. Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review. Eur Urol, 2013,63(1):125-140. [34] Mason J, Al-Qaisieh B, Bownes P, et al. Multi-parametric MRI-guided focal tumor boost using HDR prostate brachytherapy: a feasibility study. Brachytherapy, 2014,13(2):137-145. [35] 张志鹏,刘明,陈敏,等.磁共振靶向前列腺穿刺活检对前列腺癌诊断的研究.中华泌尿外科杂志,2016,37(3):161-164. [36] Zangos S, Eichler K, Thalhammer A, et al. MR-guided interventions of the prostate gland. Minim Invasive Ther Allied Technol, 2007,16(4):222-229.
